share_log

阿里健康：截至2024年3月31日之股份發行人的證券變動月報表

ALI HEALTH: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024

香港交易所 ·  Apr 3 05:49
Summary by Moomoo AI
阿里健康信息技術有限公司於2024年3月31日提交了最新的證券變動月報表，報告顯示公司的法定/註冊股本及已發行股份在本月內均無變動，維持在200億港元及20億股的水平。此外，公司股份期權計劃下，截至本月底，股份期權結存數目為26,462,744股，而本月內並無新股份因行使股份期權而發行。報告亦提及，根據股份獎勵計劃，自2014年至2024年3月期間，公司已多次授出受限制股份單位，但本月內並無新股份發行。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司的上市規則。報告由聯席公司秘書徐曉亮於2024年4月3日呈交。
阿里健康信息技術有限公司於2024年3月31日提交了最新的證券變動月報表，報告顯示公司的法定/註冊股本及已發行股份在本月內均無變動，維持在200億港元及20億股的水平。此外，公司股份期權計劃下，截至本月底，股份期權結存數目為26,462,744股，而本月內並無新股份因行使股份期權而發行。報告亦提及，根據股份獎勵計劃，自2014年至2024年3月期間，公司已多次授出受限制股份單位，但本月內並無新股份發行。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司的上市規則。報告由聯席公司秘書徐曉亮於2024年4月3日呈交。
ALI HEALTH INFORMATION TECHNOLOGY CO., LTD. FILED ITS LATEST SECURITIES MONTHLY CHANGE REPORT ON MARCH 31, 2024, SHOWING THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES REMAINED UNCHANGED DURING THE MONTH, AT HK$200 BILLION AND HK$2 BILLION. In addition, under the Company's stock option plan, as of the end of this month, the number of share options outstanding was 26,462,744 shares, and no new shares were issued during the month as a result of the exercise of share options. The report also notes that, under the Share Award Scheme, the Company issued restricted share units several times between March 2014 and 2024, but no new shares were issued during this month. The Company confirms that all securities issues have been approved by the Board of Directors and comply with the Listing Rules of the Hong Kong Stock Exchange Limited. The report was presented by the Joint Secretary of the Joint Undertaking, Xu Xiaoliang, on 3 April 2024.
ALI HEALTH INFORMATION TECHNOLOGY CO., LTD. FILED ITS LATEST SECURITIES MONTHLY CHANGE REPORT ON MARCH 31, 2024, SHOWING THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES REMAINED UNCHANGED DURING THE MONTH, AT HK$200 BILLION AND HK$2 BILLION. In addition, under the Company's stock option plan, as of the end of this month, the number of share options outstanding was 26,462,744 shares, and no new shares were issued during the month as a result of the exercise of share options. The report also notes that, under the Share Award Scheme, the Company issued restricted share units several times between March 2014 and 2024, but no new shares were issued during this month. The Company confirms that all securities issues have been approved by the Board of Directors and comply with the Listing Rules of the Hong Kong Stock Exchange Limited. The report was presented by the Joint Secretary of the Joint Undertaking, Xu Xiaoliang, on 3 April 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more